Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,593 | -29,142 | -21,249 | -13,096 | -6,018 |
| Depreciation Amortization | 77 | 59 | 38 | 21 | 9 |
| Accounts payable and accrued liabilities | 595 | 621 | 433 | 558 | 311 |
| Other Working Capital | -1,176 | 1,735 | 1,009 | 1,084 | 122 |
| Other Operating Activity | 924 | 5,980 | 4,460 | 2,828 | 1,435 |
| Operating Cash Flow | $-9,174 | $-20,746 | $-15,309 | $-8,605 | $-4,141 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -3,414 | -27,000 | -10,004 | N/A | N/A |
| PPE Investments | -107 | -266 | -223 | -76 | -26 |
| Investing Cash Flow | $-3,521 | $-27,265 | $-10,228 | $-76 | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8 | 80,844 | 80,842 | 80,838 | 80,835 |
| Financing Cash Flow | $8 | $80,844 | $80,842 | $80,838 | $80,835 |
| Beginning Cash Position | 66,687 | 33,854 | 33,854 | 33,854 | 33,854 |
| End Cash Position | 54,000 | 66,687 | 89,160 | 106,012 | 110,523 |
| Net Cash Flow | $-12,687 | $32,833 | $55,305 | $72,158 | $76,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,174 | -20,746 | -15,309 | -8,605 | -4,141 |
| Capital Expenditure | -107 | -266 | -223 | -76 | -26 |
| Free Cash Flow | -9,281 | -21,012 | -15,532 | -8,681 | -4,167 |